Table 3 Comparisons of the means of all the participants through the Friedman test between the baseline and the follow-ups in the clinical variables of the multidisciplinary treatment

BES

32.13

(4.22)

7.55

(9.33)

9.12 (6.91)

9.12 (4.79)

15.57

.001*

QEWP-R

8.38 (1.92)

3.50

(2.32)

4.75 (2.76)

4.37 (3.02)

13.58

.004*

BAI

31.75 (10.20)

11.75 (12.25)

15.12 (10.56)

12.62 (5.75)

15.96

.001*

BDI

24.12 (8.95)

7.37 (12.08)

9.00 (7.81)

5.37 (3.29)

15.03

.002*

TMMS-24

Atention

Female

28.00 (7.97)

25.14 (6.14)

25.75 (6.04)

26.87 (6.92)

2.72

.430

Male

29.00 (1.41)

26.00 (5.65)

27.00 (5.65)

27.31 (6.08)

1.31

.360

Clarity

Female

21.57 (7.45)

29.75 (7.22)

26.75 (6.20)

29.25 (7.00)

11.60

.010*

Male

23.50 (0.70)

21.50 (2.12)

29.50 (7.77)

29.75 (6.00)

4.10

.444

Regulation

Female

22.00 (5.44)

30.72 (6.75)

27.37 (6.86)

26.75 (5.80)

7.75

.050*

Male

28.00 (7.07)

28.50 (6.36)

24.00 (7.07)

24.75 (5.14)

0.28

.860